In this Section |
208118 Emergency Medicine Clinicians Reported Pregnancy Related Drug Information ResourcesTuesday, November 10, 2009
Purpose: To determine what references ED clinicians use to retrieve teratogenicity information, determine likelihood of prescribing a category A, B, C, D or X drug, and to ascertain their awareness of available pregnancy-related drug information resources.
Methods: A survey was administered to each ED clinician. The survey ascertained the top three drug information references clinicians routinely use in clinical practice; clinicians willingness to prescribe a category A, B, C, D or X drug using a 5 point Likert scale (strongly disagree to strongly agree); and clinician selected from a list of electronic and print resources those that he/she considered available to him/her in the ED to find pregnancy-related drug prescribing information. Results: To date, Forty-nine ED clinicians with a median of 2.5 years (range 1-38) in the profession filled out the survey. Seventy four percent are male, and 54% are residents practicing in both the adult and pediatric EDs. Nineteen percent of the clinicians stated that they would be willing to prescribe Category C drugs, yet 66% of the most commonly utilized drugs in the ED are Category C. The most commonly used references include Micromedex®, Tarascon Pocket Pharmacopoeia, and Epocrates® (34%, 23% and 16%, respectively). Among the 63% pregnancy-specific drug information references that are available in our EDs, less than 24% of clinicians stated that these references are available to them. Conclusion: Education on the appropriate use of category C drugs and references containing detailed pregnancy information is warranted.
Learning Objectives: Keywords: Emergency Department/Room, Pregnancy
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am one of the investigators on the study I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Emergency Medicine and Disaster Response Posters I
See more of: Injury Control and Emergency Health Services |